News Detail
Kolkata, 27 Oct 2023: Low back pain (LBP) is a global health concern. Management of LBP aims at pain relief facilitating improvement of functional ability. Non-steroidal anti-inflammatory drugs (NSAIDs) are the first line of therapy. However, the selection of NSAIDs is challengin......
View Details
Source : Cureus
fixed-dose combination (fdc)
thiocolchicoside
randomized controlled trial (rct)
low back pain (lbp)
etoricoxib
Related News
- Chinese woman finds type 1 diabetes reversed after stem cell transplant in world first (01-10-2024)
- NIAB scientists develop diagnostic kit to detect antibiotics in animal food samples (22-09-2024)
- Cancer cells may be using lipids to hide from the immune system (19-09-2024)
- Study links personal care products to increased hormonal disruptions in children (15-09-2024)
- Study Identifies Hundreds of Potential Targets for Cancer Drugs (12-09-2024)
- Protein-lipid particles to deliver genetic medicine (11-09-2024)
- Harnessing bacteriophages as targeted treatments for drug-resistant bacteria (06-09-2024)
- Chinese scientists claim to have developed hydrogel to treat arthritis: Report (03-09-2024)
- Human gut microbiome: A source of new antibiotic peptides (26-08-2024)
- IIT Kanpur-KGMU together developed a special device, to give easily CPR at home (01-08-2024)